- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Abbott Labs' shares fell nearly 1% in premarket trading after the company reported mixed earnings results.
The Federal Trade Commission says Abbott Laboratories can proceed with its proposed $25 billion acquisition of St. Jude Medical.
Abbott can now proceed with its $25 billion buy of St. Jude Medical.